Global Orthobiologics Devices And Equipment Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Global orthobiologics devices and equipment market size is expected to reach $7.39 Bn by 2028 at a rate of 6.5%, segmented as by product type, demineralized bone matrix, synthetic bone substitutes, stem cell therapy, plasma-rich protein

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Global Orthobiologics Devices And Equipment Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Overview and Scope
Orthro biologic devices are implants composed of cells and proteins that are naturally found in the human body and that provide accelerated healing by stimulating efficient regrowth of musculoskeletal tissues, including bones, cartilage, tendons, and ligaments.

Sizing and Forecast
The orthobiologics devices and equipment market size has grown strongly in recent years. It will grow from $5.29 billion in 2023 to $5.74 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%.  The  growth in the historic period can be attributed to market entry of innovative devices, clinical research and trials, rise in sports injuries and aging population, regulatory standards compliance, evolution of implant designs.

The orthobiologics devices and equipment market size is expected to see strong growth in the next few years. It will grow to $7.39 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.  The growth in the forecast period can be attributed to ai-assisted surgical planning, value-based healthcare initiatives, market expansion in emerging economies, precision surgery tools, regenerative medicine emphasis. Major trends in the forecast period include ai-assisted planning and simulation, patient-specific solutions, enhanced biologic integration, minimally invasive procedures, focus on regenerative therapies.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report


Segmentation & Regional Insights
The orthobiologics devices and equipment market covered in this report is segmented –
1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) By Application: Osteoarthritis and Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial and Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) By End Use: Hospitals, Orthopedic Clinics, Other End Users

North America was the largest region in the global Ortho biologics devices and equipment market in 2023. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp


Major Driver Impacting Market Growth
The aging population profile of most countries contributed to the growth of orthobiologics devices and equipment market globally. According to the United Nations report, there were 962 million people aged over 60 across the globe, comprising 13% of the global population. The population aged over 60 is expected to grow at a rate of about 3% every year. The report further estimated that Europe had the highest percentage of the population aged over 60. The number of people globally over the age of 65 grew by 33%, according to estimates based on Population Reference Bureau data. The increase in the aging population has increased the patient pool of many orthopedic disorders and led to an increase in the demand for orthobiologics devices and equipment market.

Key Industry Players
Major companies operating in the orthobiologics devices and equipment market report are BONESUPPORT AB, Sanofi SA, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Terumo BCT Inc., Terumo Corporation, Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Wright Medical Group NV, Bioventus LLC, Orthofix Medical Inc., Pioneer Surgical Technology Inc., RTI Surgical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp., Osiris Therapeutics Inc., K2M Group Holdings Inc., BSN medical Pvt. Ltd.

The orthobiologics devices and equipment market report table of contents includes:
1. Executive Summary
2. Orthobiologics Devices And Equipment Market Characteristics
3. Orthobiologics Devices And Equipment Market Trends And Strategies
4. Orthobiologics Devices And Equipment Market - Macro Economic Scenario
5. Global Orthobiologics Devices And Equipment Market Size and Growth
…………………
32. Global Orthobiologics Devices And Equipment Market Competitive Benchmarking
33. Global Orthobiologics Devices And Equipment Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Orthobiologics Devices And Equipment Market
35. Orthobiologics Devices And Equipment Market Future Outlook and Potential Analysis
36. Appendix